Bevacizumab (Avastin).
Middleton
Gena
G
Genentech BioOncology, Middleton, OH, USA. gena@gene.com
Lapka
Denise V
DV
D000911:Antibodies, Monoclonal / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000378:metabolism / Q000451:nursing; D004334:Drug Administration Schedule; D004347:Drug Interactions; D016903:Drug Monitoring / Q000379:methods / Q000451:nursing; D006801:Humans; D008657:Metabolic Clearance Rate; D024802:Nurse's Role; D009859:Oncology Nursing / Q000379:methods; D010353:Patient Education as Topic; D018579:Patient Selection
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab